Investigating the risk of recurrent cervical artery dissection after pregnancy
Official title: Long-term Risk of Recurrent Cervical Artery Dissection After Pregnancy (LONG-RECAP Study)
Run by University Hospital, Basel, Switzerland · NCT06258109 · Data updated 2026-11-12
This study is trying to see if having a baby increases the chances of women who have had cervical artery dissection getting it again or having a stroke.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 1000 (estimated) |
| Sponsor | University Hospital, Basel, Switzerland Academic / other |
| Locations | 12 sites (Salt Lake City, Utah and 11 other locations) |
| Status | Recruiting |
| Started | January 1, 2023 |
| Main results expected | December 1, 2024 |
| Study ends | July 1, 2025 |
| Registry record updated | December 13, 2024 |
| Trial ID | NCT06258109 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 18 and older who have a history of symptomatic cervical artery dissection and have undergone long-term follow-up.
✕Probably not a fit
Patients who are male or under 18 years old, or those without long-term follow-up data will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to determine if pregnancy increases the risk of recurrent cervical artery dissection (CeAD) and delayed stroke in women who have previously experienced CeAD. It will utilize pooled individual patient data from multiple stroke centers, focusing on long-term follow-up of women with prior CeAD. The primary endpoint includes the occurrence of recurrent CeAD, ischemic or hemorrhagic stroke, and death. The study will also explore the impact of delivery mode on recurrence and whether women chose to avoid pregnancy due to their initial CeAD.
Why it matters
Potential benefit: If successful, this study could provide critical insights into the risks associated with pregnancy for women with a history of cervical artery dissection.
How similar studies have gone: Previous studies on this topic have been limited by small sample sizes and lack of long-term data, making this approach relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * female * prior symptomatic cervical artery dissection (= index CeAD) * at least one long-term follow-up visit (at least 6 months after the initial event) * with information available on outcome events: * recurrent dissection * ischemic stroke * hemorrhagic stroke * functional outcome assessed by mRS score * with data on pregnancy after the initial event * at least 18 years old at the initial event Exclusion Criteria: * Male patients * Age \<18 years * No long-term follow-up available or long-term follow-up \< 6 months after initial event * No data on pregnancy after initial event available
Where it's running
-
University of Utah
Salt Lake City, Utah, United States Recruiting -
University of Virginia
Charlottesville, Virginia, United States Recruiting -
Stroke Unit Sanatorio Allende
Córdoba, Argentina Recruiting -
Department of Neurology, Medical University of Innsbruck
Innsbruck, Tyrol, Austria Recruiting -
Helsinki University Central Hospital
Helsinki, Finland Recruiting -
Charité Universitätsmedizin, Centrum für Schlaganfallforschung
Berlin, Germany Recruiting
Show 6 more locations
-
Neurologische Klinik und Poliklinik, LMU Klinikum Campus Großhadern
Munich, Germany Recruiting -
Hadassah-Hebrew University Medical Center
Jerusalem, Israel Recruiting -
Neurology Clinic, University of Brescia
Brescia, Italy Recruiting -
Stroke Clinic, National Institute of Neurology and Neurosurgery Manuel Velasco Suárez
Mexico City, Mexico Recruiting -
University Hospital Basel, Stroke Center
Basel, Switzerland Recruiting -
University Hospital Zurich, Stroke Center
Zurich, Switzerland Recruiting
Study contacts
- Principal investigator: Stefan T Engelter, MD — University Hospital, Basel, Switzerland
- Study coordinator: Stefan T Engelter, MD
- Email: stefan.engelter@felixplatter.ch
- Phone: +41 61 326 41 05
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Two-Door Doulas: Enhanced vs Standard Medicaid Doula Care in Pregnancy
This trial tests whether an enhanced, earlier, and more frequent doula support program helps pregnant people on Medicaid feel less depression and anxiety after birth compared with the standard Medicaid doula care in Florida.
-
ASPIRE: Predicting Pregnancy Complications Using Blood and Eye Imaging
This study tests whether blood and eye imaging biomarkers can predict conditions like preeclampsia, fetal growth restriction, and gestational diabetes in first-time pregnant people carrying one baby.
-
Womb Watch: using a smartphone app to detect fetal movements
This study tests a smartphone app to help pregnant people track fetal movements and see if it can better detect movement changes that might signal risk.
-
Maternal insulin and fat metabolism in pregnancies at risk for preeclampsia and gestational diabetes
This project will try to see if insulin resistance and how the body burns fats early in pregnancy predict later preeclampsia or gestational diabetes in people at higher risk.
-
Leg vs Arm Ergometer Exercise for Gestational Diabetes
This study tests whether leg-ergometer exercise helps control blood sugar and reduce stress more than arm-ergometer exercise in pregnant people with gestational diabetes.
-
MOCHA: Inpatient Mental Health Care for High-Risk Pregnancy
This study tests a collaborative mental health program for pregnant or recently postpartum patients hospitalized for medical problems to see if it can be delivered feasibly and acceptably.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.